Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients—A Systematic Review-Reference-Cited by-同舟云学术

Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients—A Systematic Review

Published:2016-12 Issue:6 Volume:16 Page:456-470
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Dudani Shaan^ORCID,Mazzarello Sasha,Hilton John,Hutton Brian,Vandermeer Lisa,Fernandes Ricardo,Ibrahim Mohammed F.K.,Smith Stephanie,Majeed Habeeb,Al-Baimani Khalid,Caudrelier Jean-Michel,Shorr Risa,Clemons Mark

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference92 articles.

1. Neoplastic meningitis;Aparicio;Curr Neurol Neurosci Rep,2002

2. Leptomeningeal carcinomatosis;Grossman;Cancer Treat Rev,1999

3. Survival of breast cancer patients with meningeal carcinomatosis;Gauthier;Ann Oncol,2010

4. Neoplastic meningitis;Chamberlain;Neurologist,2006

5. Leptomeningeal metastases in the MRI era;Clarke;Neurology,2010

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DEGRO guideline for personalized radiotherapy of brain metastases and leptomeningeal carcinomatosis in patients with breast cancer;Strahlentherapie und Onkologie;2024-03-15

2. Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature;Frontiers in Oncology;2024-01-10

3. Leptomeningeal Metastasis in Triple-Negative Breast Cancer: A Retrospective Study;2024

4. An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?;Expert Review of Neurotherapeutics;2023-12-25

5. Supplementary FCO 2023;Forum of Clinical Oncology;2023-12-01